It is known that the constitutive activation of the JAK3/STATs/NF-κB pathway is related to abnormal cytokines/chemokines or Th1/Th2 shift in CTCL [33]. This evidence concerns the gene JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma.